BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 9, Issue 12
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (3543)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-3) series.
Item 
Count 
PDF409
HTML2947
Figures (1-3)187
 Sum=3543
Dec 15, 2003 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Geier A, Gartung C, Dietrich CG, Wasmuth HE, Reinartz P, Matern S. Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC. World J Gastroenterol 2003; 9(12): 2681-2685 [PMID: 14669312 DOI: 10.3748/wjg.v9.i12.2681]
URL: https://www.wjgnet.com/1007-9327/full/v9/i12/2681.htm
Number Citing Articles
1
Albert J. Czaja. The Overlap Syndromes of Autoimmune Hepatitis. Digestive Diseases and Sciences 2012;  doi: 10.1007/s10620-012-2367-1
2
Michael Lin, S. Chris Pappas. Managing Gastrointestinal Complications of Diabetes. 2017; : 93 doi: 10.1007/978-3-319-48662-8_7
3
Albert J Czaja. Current and future treatments of autoimmune hepatitis. Expert Review of Gastroenterology & Hepatology 2009; 3(3): 269 doi: 10.1586/egh.09.15
4
Jia Kang, Tong Zhang, Hongyue Wang, Caihong Shi, Xiangrong Zhang. Chitosan nanoparticles loaded with velvet antler polypeptides for intervention in autoimmune hepatitis. Food Bioscience 2024; 62: 105102 doi: 10.1016/j.fbio.2024.105102
5
Albert J. Czaja. Diagnosis and Management of Autoimmune Hepatitis. Clinics in Liver Disease 2015; 19(1): 57 doi: 10.1016/j.cld.2014.09.004
6
Yasuhiro Miyake. Autoimmune Liver Diseases. 2014; : 95 doi: 10.1007/978-4-431-54789-1_7
7
Ja Kyung Kim. Treatment of Autoimmune Hepatitis. The Korean Journal of Gastroenterology 2023; 81(2): 72 doi: 10.4166/kjg.2023.011
8
John M. Vierling. Diagnosis and Treatment of Autoimmune Hepatitis. Current Gastroenterology Reports 2012; 14(1): 25 doi: 10.1007/s11894-011-0236-2
9
Albert J Czaja. Drug choices in autoimmune hepatitis: Part A – steroids. Expert Review of Gastroenterology & Hepatology 2012; 6(5): 603 doi: 10.1586/egh.12.40
10
Silja Steinmann, Ansgar W. Lohse. Treatment of autoimmune hepatitis: Budesonide does not solve our problems. Hepatology 2023; 77(4): 1071 doi: 10.1097/HEP.0000000000000183
11
Ignasi Olivas, Marina Cobreros, María-Carlota Londoño, Álvaro Díaz-González. Budesonide in the first line treatment of patients with autoimmune hepatitis. Gastroenterología y Hepatología (English Edition) 2022; 45(7): 561 doi: 10.1016/j.gastre.2021.11.003
12
Thejus Jayakrishnan, Meera Babu, Steven Goodnow, Brent Hardman. Budesonide-Induced Hyperosmolar Hyperglycemic State Following Transjugular Intrahepatic Portosystemic Shunt. AACE Clinical Case Reports 2020; 6(5): e265 doi: 10.4158/ACCR-2020-0216
13
A. J. Czaja. Review article: the management of autoimmune hepatitis beyond consensus guidelines. Alimentary Pharmacology & Therapeutics 2013; 38(4): 343 doi: 10.1111/apt.12381
14
Iliana Doycheva, Kymberly D. Watt, Aliya F. Gulamhusein. Autoimmune hepatitis: Current and future therapeutic options. Liver International 2019; 39(6): 1002 doi: 10.1111/liv.14062
15
Nancy S. Reau, Craig S. Lammert, Ethan M. Weinberg. Autoimmune hepatitis: Current and future therapies. Hepatology Communications 2024; 8(6) doi: 10.1097/HC9.0000000000000458
16
Saeed Mohammad. Budesonide as first-line therapy for non-cirrhotic autoimmune hepatitis in children: a decision analysis. Scandinavian Journal of Gastroenterology 2016; 51(6): 753 doi: 10.3109/00365521.2015.1130166
17
Albert J. Czaja. Liver Disorders. 2017; : 217 doi: 10.1007/978-3-319-30103-7_15
18
Raj A Shah, Kris V Kowdley. Current and potential treatments for primary biliary cholangitis. The Lancet Gastroenterology & Hepatology 2020; 5(3): 306 doi: 10.1016/S2468-1253(19)30343-7
19
AbdulrahmanA Aljumah, Badr Al Jarallah, Ali Albenmousa, Abdullah Al Khathlan, Adnan Al Zanbagi, Mohammed Al Quaiz, Bandar Al-Judaibi, Khalid Nabrawi, Waleed Al Hamoudi, Mohammed Alghamdi, Hind Fallatah. The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis. Saudi Journal of Gastroenterology 2018; 24(7): 1 doi: 10.4103/sjg.SJG_159_18
20
Albert J Czaja. Current and prospective pharmacotherapy for autoimmune hepatitis. Expert Opinion on Pharmacotherapy 2014; 15(12): 1715 doi: 10.1517/14656566.2014.931938
21
Ignasi Olivas, Marina Cobreros, María-Carlota Londoño, Álvaro Díaz-González. Budesonide in the first line treatment of patients with autoimmune hepatitis. Gastroenterología y Hepatología 2022; 45(7): 561 doi: 10.1016/j.gastrohep.2021.11.012
22
A. D. YEOMAN, M. S. LONGHI, M. A. HENEGHAN. Review article: the modern management of autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 2010; 31(8): 771 doi: 10.1111/j.1365-2036.2010.04241.x
23
C. Corpechot, O. Chazouillères. Hépatites auto-immunes : actualités diagnostiques et thérapeutiques. La Revue de Médecine Interne 2010; 31(9): 606 doi: 10.1016/j.revmed.2009.05.015
24
John M. Vierling. Autoimmune Hepatitis and Overlap Syndromes: Diagnosis and Management. Clinical Gastroenterology and Hepatology 2015; 13(12): 2088 doi: 10.1016/j.cgh.2015.08.012
25
Farhad Sahebjam, John M. Vierling. Autoimmune hepatitis. Frontiers of Medicine 2015; 9(2): 187 doi: 10.1007/s11684-015-0386-y
26
Andrew S. deLemos. Diagnosis and Management of Autoimmune Hepatitis. 2020; : 81 doi: 10.1007/978-3-030-33628-8_5
27
Albert J Czaja. Clinical Features, Differential Diagnosis and Treatment of Autoimmune Hepatitis in the Elderly. Drugs & Aging 2008; 25(3): 219 doi: 10.2165/00002512-200825030-00005
28
Eve A. Roberts. Autoimmune hepatitis from the paediatric perspective. Liver International 2011; 31(10): 1424 doi: 10.1111/j.1478-3231.2011.02603.x
29
V. Selvarajah, A. J. Montano‐Loza, A. J. Czaja. Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs. Alimentary Pharmacology & Therapeutics 2012; 36(8): 691 doi: 10.1111/apt.12042
30
Teru Kumagi, Khalid Alswat, Gideon M. Hirschfield, Jenny Heathcote. New insights into autoimmune liver diseases. Hepatology Research 2008; 38(8): 745 doi: 10.1111/j.1872-034X.2008.00366.x
31
Aldo J Montano Loza, Albert J Czaja. Current therapy for autoimmune hepatitis. Nature Clinical Practice Gastroenterology & Hepatology 2007; 4(4): 202 doi: 10.1038/ncpgasthep0768
32
Albert J Czaja, Yusuf Bayraktar. Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment. World Journal of Gastroenterology 2009; 15(19): 2314-2328 doi: 10.3748/wjg.15.2314
33
Albert J Czaja. Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. Gut and Liver 2016; 10(2): 177 doi: 10.5009/gnl15352
34
Andréanne N. Zizzo, Pamela L. Valentino, Prakesh S. Shah, Binita M. Kamath. Second‐line Agents in Pediatric Patients With Autoimmune Hepatitis. Journal of Pediatric Gastroenterology and Nutrition 2017; 65(1): 6 doi: 10.1097/MPG.0000000000001530
35
Cara L. Mack, David Adams, David N. Assis, Nanda Kerkar, Michael P. Manns, Marlyn J. Mayo, John M. Vierling, Mouaz Alsawas, Mohammad H. Murad, Albert J. Czaja. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology 2020; 72(2): 671 doi: 10.1002/hep.31065
36
Natanie J. Anilovich. Oral budesonide is an effective alternative to prednisone for treatment of autoimmune hepatitis. Clinical Research In Practice: The Journal of Team Hippocrates 2021; 7(2) doi: 10.22237/crp/1622160960
37
Dorothy Liu, William M. W. Bonwick, Priya Sumithran, Josephine A. Grace, Marie Sinclair. Budesonide in Liver Immunology: A Therapeutic Opportunity in Liver Transplantation. Current Transplantation Reports 2024; 11(4): 197 doi: 10.1007/s40472-024-00441-9
38
Syed Rizvi, Samer Gawrieh. Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management. Drugs & Aging 2018; 35(7): 589 doi: 10.1007/s40266-018-0556-0
39
Lydia A. Mercado, Fernando Gil-Lopez, Razvan M. Chirila, Denise M. Harnois. Autoimmune Hepatitis: A Diagnostic and Therapeutic Overview. Diagnostics 2024; 14(4): 382 doi: 10.3390/diagnostics14040382
40
T. O. Lankisch, C. P. Strassburg, M. P. Manns. Autoimmune Liver Disease. Falk Symposium 2005; 142: 193 doi: 10.1007/1-4020-2914-4_18
41
Albert J. Czaja. Liver Disorders. 2017; : 307 doi: 10.1007/978-3-319-30103-7_18
42
Albert J. Czaja. Evolving paradigm of treatment for autoimmune hepatitis. Expert Review of Clinical Immunology 2017; 13(8): 781 doi: 10.1080/1744666X.2017.1319764
43
Agnes Nuo Han, Beatrice Rae Han, Tao Zhang, Tycho Heimbach. Hepatic Impairment Physiologically Based Pharmacokinetic Model Development: Current Challenges. Current Pharmacology Reports 2021; 7(6): 213 doi: 10.1007/s40495-021-00266-5
44
Luigi Muratori, Paolo Muratori, Alessandro Granito, Giorgios Pappas, Fabio Cassani, Marco Lenzi. Current topics in autoimmune hepatitis. Digestive and Liver Disease 2010; 42(11): 757 doi: 10.1016/j.dld.2010.05.019
45
Paul A. Schmeltzer. Diagnosis and Management of Autoimmune Hepatitis. 2020; : 93 doi: 10.1007/978-3-030-33628-8_6
46
Albert J. Czaja, Michael P. Manns. Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis. Gastroenterology 2010; 139(1): 58 doi: 10.1053/j.gastro.2010.04.053
47
Albert J. Czaja. Advances in the Current Treatment of Autoimmune Hepatitis. Digestive Diseases and Sciences 2012; 57(8): 1996 doi: 10.1007/s10620-012-2151-2
48
EASL Clinical Practice Guidelines: Autoimmune hepatitis. Journal of Hepatology 2015; 63(4): 971 doi: 10.1016/j.jhep.2015.06.030
49
O. Chazouillères. Un cas d’hépatite auto-immune. Gastroentérologie Clinique et Biologique 2009; 33(10-11): F36 doi: 10.1016/j.gcb.2009.07.015
50
Brian H Le, Ghauri Aggarwal, Carol Douglas, Michael Green, Amanda Nicoll, Sam Ahmedzai. Oxycodone/naloxone prolonged‐release tablets in patients with moderate‐to‐severe, chronic cancer pain: Challenges in the context of hepatic impairment. Asia-Pacific Journal of Clinical Oncology 2022; 18(1): 13 doi: 10.1111/ajco.13561
51
Nahum Méndez-Sánchez, Carlos E. Coronel-Castillo, Ana L. Ordoñez-Vázquez. Current Therapies for Cholestatic Diseases. Biomedicines 2023; 11(6): 1713 doi: 10.3390/biomedicines11061713
52
Charles Ronsin, Pierre Braud, Christine Kandel-Aznar, Amaury Dujardin, Clémence Petit, David Larmet, Claire Garandeau, Clément Deltombe, Alice Le Clech, Claire Leman, Gilles Blancho, Juliet Schurder, Grégoire Couvrat-Desvergnes, Simon Ville. Clinical Presentation, Pathological Spectrum, and Outcomes of Alcoholic Cirrhosis-Related Immunoglobulin A Nephropathy. Kidney International Reports 2024; 9(5): 1369 doi: 10.1016/j.ekir.2024.02.1397
53
Albert J. Czaja, Herschel A. Carpenter. Autoimmune Hepatitis Overlap Syndromes and Liver Pathology. Gastroenterology Clinics of North America 2017; 46(2): 345 doi: 10.1016/j.gtc.2017.01.008
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345